Elanco Animal Health (ELAN) Capital Expenditures Growth (3y) (2020 - 2026)
Elanco Animal Health (ELAN) Capital Expenditures Growth (3y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 6.52% |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 232.22% |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 34.64% |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 147.53% |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 28.56% |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -15.83% |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | -61.38% |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 89.86% |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn | 277.94% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 28.56% |
| Dec 31, 2025 | -6.97% |
| Sep 30, 2025 | 36.72% |
| Jun 30, 2025 | 3.78% |
| Mar 31, 2025 | 110.19% |
| Dec 31, 2024 | -31.77% |
| Sep 30, 2024 | 55.36% |
| Jun 30, 2024 | 4.26% |
| Mar 31, 2024 | 68.69% |
| Dec 31, 2023 | -29.90% |
| Sep 30, 2023 | 40.10% |
| Jun 30, 2023 | -3.68% |
| Mar 31, 2023 | 22.67% |
| Dec 31, 2022 | 54.69% |
| Sep 30, 2022 | 62.71% |
| Jun 30, 2022 | 1.14% |
| Mar 31, 2022 | 40.95% |
| Dec 31, 2021 | 59.36% |
| Sep 30, 2021 | -49.60% |
| Jun 30, 2021 | 8.02% |